What is the 10‑year atherosclerotic cardiovascular disease (ASCVD) risk for a 59‑year‑old non‑Hispanic White female, non‑smoker, with untreated hypotension, total cholesterol 211 mg/dL, high‑density lipoprotein cholesterol (HDL‑C) 61 mg/dL, and low‑density lipoprotein cholesterol (LDL‑C) 145 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ASCVD Risk Calculation

Based on the provided parameters, this 59-year-old non-Hispanic White female non-smoker has an estimated 10-year ASCVD risk of approximately 3-5%, placing her in the low-risk category.

Risk Calculation Using Pooled Cohort Equations

The 2013 ACC/AHA Pooled Cohort Equations 1 are the guideline-recommended tool for calculating 10-year ASCVD risk. For this patient:

Input Variables:

  • Age: 59 years
  • Sex: Female
  • Race: Non-Hispanic White
  • Total cholesterol: 211 mg/dL
  • HDL cholesterol: 61 mg/dL
  • Systolic blood pressure: 105 mmHg (untreated)
  • Diabetes: No
  • Current smoker: No

Risk Stratification:

This patient's profile indicates low 10-year ASCVD risk (<5%) based on the following favorable factors:

  • Excellent blood pressure control (105/51 mmHg, well below treatment thresholds)
  • Good HDL cholesterol (61 mg/dL, protective level)
  • Non-smoker status
  • No diabetes
  • Moderately elevated total cholesterol (211 mg/dL) and LDL (145 mg/dL), but not at major risk factor thresholds

According to the ACC/AHA risk stratification framework 1, she falls into the category of having risk factors at "nonoptimal levels" (untreated total cholesterol 180-199 mg/dL range guidance, though hers is slightly higher at 211 mg/dL, and untreated systolic BP 120-139 mm Hg, though hers is lower at 105 mm Hg), which typically corresponds to lifetime ASCVD risk of 27-36% but 10-year risk remaining low.

Clinical Context and Newer Evidence

Recent data suggests the Pooled Cohort Equations may overestimate risk in certain populations. The 2024 PREVENT equations 2 estimate lower ASCVD risk compared to the original Pooled Cohort Equations, with mean estimated 10-year risk dropping from 8.0% to 4.3% nationally. The largest reductions in estimated risk were seen in older adults aged 70-75 years and Black adults.

For this specific patient at age 59 with favorable risk factors except mildly elevated cholesterol, her actual 10-year risk likely falls in the 3-5% range, consistent with low-risk classification.

Important Caveats

  • Blood pressure notation: The stated BP of 105/51 mmHg is unusually low. If this represents hypotension or measurement error, verification is warranted, though it would not increase ASCVD risk.

  • LDL cholesterol: At 145 mg/dL, this is above optimal but does not meet the threshold for a "major risk factor" (≥240 mg/dL total cholesterol) as defined in the guidelines 1.

  • Risk factor updating: Guidelines recommend measuring and updating ASCVD risk factors every 4-6 years to improve prediction accuracy 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.